Video: 2022 M&A Transactional Outlook Part 2

Andre Ulloa provides the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.

M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy.

Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.

“Specialty pharmacy valuations have remained stable in recent years in spite of downward pressure on sales, gross margin and net income,” Ulloa said.

While certain segments of the pharmacy market remain strong, not all of them have fared as well recently.


More From M&A Healthcare Advisors

Pharmacy Successful Transaction
Should Anyone On My Staff Know I’m Selling My Business?
Pharmacy Successful Transaction
M&A Healthcare Advisors Represents Greater Boston Long Term Care Pharmacy In Their Sale to Tarrytown Expocare Pharmacy
Pharmacy Successful Transaction
The Role & Importance of the Quality of Earnings (QoE) Process in Healthcare M&A
{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Get in touch

Name*
Email*
Message
0 of 350